Jefferies downgraded RBLX to Underperform on September 28 with a $38 price target. The stock closed at $41.18 on September 29, down 17.4% on the week. October 30 earnings are now 30 days away.
The Jefferies cut is the sharpest analyst move in recent weeks. James Heaney assigned a $38 target, below the current price and well below the consensus mean of $49.31. The broader analyst picture is divided. Needham's Bernie McTernan raised his target to $55 on September 23, keeping a Buy. Roth Capital's Eric Handler went to $60. Wells Fargo lifted its Overweight target from $46 to $64. Against those, BTIG maintains a Sell and Macquarie sits at Neutral with a $37 target, in line with Jefferies. The consensus sits at Hold across 15 holds, three sells, and a cluster of buys.
The gap between the $38 bear target and the $64 bull target is unusually wide. That spread reflects genuine disagreement about the company's trajectory, not noise.
The put-call ratio has climbed steadily over the past week. It sat at 0.6375 on September 29, 2.0 standard deviations above its 20-day mean of 0.577. That is the highest level in three weeks. The 52-week range runs from 0.37 to 0.93, so the current reading sits in elevated but not extreme territory. The direction matters: the PCR was near 0.54 through most of September and has moved consistently higher since the Jefferies downgrade landed.
This follows a July 30 earnings print that sent the stock down 29% in a single session, a move that held over the following five days. Options traders appear to be pricing in the possibility of a repeat.
Cost to borrow rose to 1.57% on September 29, up 221% over the prior week. That move is sharp in percentage terms. In absolute terms, the rate remains low: the borrow had been running between 0.20% and 0.61% through most of August and September before the sudden spike. Availability remains very loose at 5,247%, meaning shares are in plentiful supply relative to short demand. The CTB spike may reflect a short-term technical dislocation around the downgrade rather than a sustained tightening of the lending market.
Short interest stands at 3.74% of the free float, roughly flat on the week. As noted in the September 23 article, the more significant shift happened earlier in September when the short share count nearly doubled from around 13 million to over 24 million shares in the space of a week. That level has held since. Retail attention, per Wikipedia page views, is running 1.6 standard deviations above the stock's own 90-day history.
The key date is October 30. The Jefferies downgrade, rising PCR, and the July earnings disaster create a clear set-up for elevated pre-earnings hedging activity. Whether the CTB spike proves durable or fades back toward prior levels will signal whether short demand is genuinely building or simply reacting to the headline downgrade.
See the live data behind this article on ORTEX.
Open RBLX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
